Varied Differentiation Responses of Human Leukemias to Bryostatin

Cancer Research

Volumn 49, Issue 5, 1989, Pages 1287-1293

  Kraft, Andrew S ^a   William, Felicia ^a   Pettit, George R ^b   Lilly, Michael B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1;

CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CYTOCHEMISTRY; CYTOLOGY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; HUMAN; LACTONES; LEUKEMIA; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; PROTEIN KINASE C; PROTO-ONCOGENES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0024504383     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pegoraro, L., Abrahm, J., Cooper, R. A., Levis, A., Lange, B., Meo, P., and Rover, G. Differentiation of human leukemias in response to 12-O-tetrade-canoylphorbol-13-acetate in vitro. Blood, 55:859-862,1980.
2. Huberman, E., and Callaham, M. F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc. Natl. Acad. Sci. USA, 76:1295-1297,1979.
3. Tucker, K. A., Lilly, M. B., Heck, L., and Rado, T. A. Characterization of a new human diploid myeloid leukemia cell line ^LB-985) with granulocytic and monocytic differentiating capacity. Blood, 70:372-378,1988.
4. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (Lond.), 308:693-698,1984.
5. Kraft, A. S., and Anderson, W. B. Phorbol esters increase the amount of calcium, phospholipid-dependent protein kinase associated with plasma membrane. Nature (Lond.), 301:621-623,1983.
6. Pettit, B. R., Herald, C. L., Doubek, D. L., and Herald, D. L. Isolation and structure of bryostatin 1. J. Am. Chem. Soc., 104:6846-6848,1982.
7. Pettit, G. R., Herald, C. L., Kamano, Y., Gust, D., and Aoyagi, R. The structure of bryostatin 2 from the marine bryozoan Buguia neritina. J. Natural Prod., 46:528-531,1983.
8. Pettit, G. R., Kamano, Y., and Herald, C. L. Isolation and structure of bryostatins 10 and 11. J. Chem., 52:2848-2854,1987.
9. Kraft, A. S., Smith, J. B., and Berkow, R. L. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc. Natl. Acad. Sci. USA, 83:1334-1338,1986.
10. Smith, J. B., Smith, L., and Pettit, G. R. Bryostatins: potent new mitogens that mimic phorbol ester tumor promoters. Biochem. Biophys. Res. Commun., 752; 939-945,1985.
11. Berkow, R. L., and Kraft, A. S. Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. Biochem. Biophys. Res. Commun., 131: 1109-1116,1985.
12. Pasti, G., Rivedal, E., Yuspa, S. H., Herald, C. L., Pettit, G. R., and Blumberg, P. M. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and bryostatin 1. Cancer Res., 48:447-451,1988.
13. Ramsdell, J. S., Pettit, G. R., and Tashjian, A. H. Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells. J. Biol. Chem., 261:17073-17080,1986.
14. Kraft, A. S., Reeves, J. A., and Ashendel, C. L. Differing modulation of protein kinase C by bryostatin 1 and phorbol esters in JB6 mouse epidermal ceUs. J. Biol. Chem., 263:8437-8442,1988.
15. Dell'Aquila, M. L., Nguyen, H. T., Herald, C. L., Pettit, G. R., and Blumberg, P. M. Bryostatin 1 inhibits the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. Cancer Res., 47:6006-6009,1987.
16. Pettit, G. R., Day, J. F., Hartwell, J. L., and Wood, H. B. Antineoplastk components of marine animals. Nature (Lond.), 227:962-963,1970.
17. Hennings, H., Blumberg, P. M., Pettit, G. R., Herald, C. L., Shores, R., and Yuspa, S. H. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in Senear mouse skin. Carcinogenesis (Lond.), 8:1343-1346,1987.
18. William, F., Cohen, S., and Kraft, A. S. Differentiation of HL-60 cells is associated with increases in the 35 kDa substrate of the EGF receptor/ protein kinase. J. Cell. Biochem., 12A: 207,1988.
19. De, B. K., Misono, K. S., Lukas, T. J., Mroczkowski, B., and Cohen, S. A calcium-dependent 3S-kilodalton substrate for epidermal growth factor recep-tor/kinase isolated from normal tissue. J. Biol. Chem., 261: 13784-13792, 1986.
20. Kraft, A. S., and Anderson, W. B. Characterization of cytosolic calcium-activated phospholipid-dependent protein kinase activity in embryonal carcinoma cells. J. Biol. Chem., 258:9178-9183,1983.
21. Chomezynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159,1987.
22. Thomas, P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA, 77: 5201-5205, 1980.
23. Favera, R. D., Gelman, E. P., Martinotti, S., Franchini, G., Papas, T. S., Gallo, R. C., and Wong-Stall, F. Cloning and characterization of different human sequences related to the one gene (v-myc) of avian myelocytomatosis virus (MC29). Proc. Natl. Acad. Sci. USA, 79:6497-6501,1982.
24. Dalton, W. T., Aheam, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A., and Trujillo, J. M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-Mj. Blood, 71:242-247,1988.
25. Wickstrom, E. L., Bacon, T. A., Gonzalez, A., et al. Human promyelocytk leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA, 85:1028-1032,1988.
26. Reitsma, P. H., Rothberg, P. G., Astrin, S. M., et al. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (Lond.), 306:492-494,1983.
27. Schlaepfer, D. D., and Haigler, H. T. In vitro protein kinase C phosphorylation sites of placental lipocortin. Biochemistry, 27:4253-4258,1988.
28. Cirino, G., Flower, R. J., Browning, J. L., Sinclair, L. K., and Pepinsky, R. B. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature (Lond.), 328:270-272, 1987.
29. Kronke, M., Schulter, C., and Pfizenmaier, K. Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA, 84:469-471, 1987.
30. Kraft, A. S., Baker, V. V., and May, W. S. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). Oncogene, 1: 111-118, 1987.
31. Sako, T., Yuspa, S. H., Herald, C. L., Pettit, G. R., and Blumberg, P. M. Partiiu parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res., 47: 5445-5450,1987.
32. Pasti, G., Rivedal, E., Yuspa, S. H., et al. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and bryostatin 1. Cancer Res., 48:447-451,1988.
33. Fields, A. P., Pettit, G. R., and May, W. S. Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J. Biol. Chem., 263: 8253-8260,1988.
34. Stone, R. M., Sariban, E., Pettit, G. R., and Kufe, D. W. Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood, 72:208-213,1988.
35. Cayre, Y., Raynal, M.-C., Darzynkiewicz, Z., and Domer, M. H. Model for intermediate steps in monocytic differentiation: c-myc, c-fms, and ferritin as markers. Proc. NaU. Acad. Sci. USA, 84:7619-7623,1987.
36. Leftwich, J. A., Carlson, P., Adelman, B., and Hall, R. E. HL-60-1E3, a novel phorbol diester-resistant HL-60 cell line. Cancer Res., 47:1319-1324, 1987.
37. Malvoison, E., Wild, F., and Zwingelstein, G. Relationship between membrane sterol composition and responsiveness to 12-O-tetradecanoylphorbol 13-acetate in HL-60 human promyelocytic leukemia cell lines. Biochem. J., 250:349-353,1988.
38. Weinberg, J. B., and Larrick, J. W. Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumor necrosis factor Synergistic actions with interferon-γ 1,25-dihydroxyvitamin D3. Blood, 70: 994-1002, 1987.
39. Bennett, J. M., et al. Proposals for the classification of the acute leukaemias, French-American-British (FAB) Cooperative Group. Br. J. Hematol., 33: 451-454,1976.
40. William, F., Mroczkowski, B., Cohen, S., and Kraft, A. S. Differentiation of HL-60 cells is associated with an increase in the 35 kDa substrate Oipocortin 1) of the EGF receptor/protein kinase. J. Cell. Physiol., 137:402-410,1988.